PCFFS
BMY.RT

Pacific Center for Financial Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Pacific Center for Financial Services’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed – – 352
2020
Q4 		$0 Hold
5
– – ﹤0.01% 352
2020
Q3 		$0 Hold
5
– – ﹤0.01% 326
2020
Q2 		$0 Hold
5
– – ﹤0.01% 326
2020
Q1 		$0 Hold
5
– – ﹤0.01% 325
2019
Q4 		$0 Buy
+5
New +$13 ﹤0.01% 340

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Pacific Center for Financial Services's BMY.RT Position: Q1 2021 in Review

Pacific Center for Financial Services sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 5 shares.

Pacific Center for Financial Services first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Pacific Center for Financial Services reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Pacific Center for Financial Services sold 5 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Pacific Center for Financial Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Pacific Center for Financial Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Pacific Center for Financial Services's 13F filing for Q1 2021, filed 17 May 2021.